Cost Effectiveness of Pentavalent Rotavirus Vaccine (Rv5) in Slovenia

Value in Health - United Kingdom
doi 10.1016/j.jval.2014.08.1558
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Determining the Effectiveness of the Pentavalent Rotavirus Vaccine Against Rotavirus Hospitalizations and Emergency Department Visits Using Two Study Designs

Vaccine
Molecular MedicinePublic HealthVeterinaryMicrobiology EnvironmentalImmunologyInfectious DiseasesOccupational Health
2013English

Cost-Effectiveness of Introducing a Rotavirus Vaccine in Developing Countries: The Case of Mexico

BMC Infectious Diseases
Infectious Diseases
2008English

Health Impact and Cost-Effectiveness of a Domestically-Produced Rotavirus Vaccine in India: A Model Based Analysis

PLoS ONE
Multidisciplinary
2017English

Cost-Effectiveness Analysis of Routine Rotavirus Vaccination in Brazil

Revista Panamericana de Salud Publica/Pan American Journal of Public Health
EnvironmentalPublic HealthOccupational Health
2008English

PGI7 the Cost-Effectiveness of Rotavirus Vaccination in Guangzhou, China

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2012English

Cost-Effectiveness of Rotavirus Vaccination for Under-Five Children in Iran

Iranian Journal of Pediatrics
Child HealthPediatricsPerinatology
2015English

Efficacy of the Pentavalent Rotavirus Vaccine, RotaTeq®, in Finnish Infants Up to 3 Years of Age: The Finnish Extension Study

European Journal of Pediatrics
Child HealthPediatricsPerinatology
2010English

Quadrivalent HPV Vaccine in Argentina: Cost-Effectiveness Analysis

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Rotavirus Vaccine for Neonates

Acta Paediatrica, International Journal of Paediatrics
MedicineChild HealthPediatricsPerinatology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy